| Molecular formula | C78H123N23O23S2 |
| Molecular weight | 1815.1 g/mol |
| Registered trials | 0 |
| PubChem CID | 71300630 |
Anyone researching AOD-9604 usually wants to know whether it has cleared any regulatory approval or clinical testing. As of the most recent data reviewed, it has not.
Regulatory Status
AOD-9604 is classified as an unapproved research compound. It carries no FDA-approved label, no approved brand name, and no approved indication for any medical use.
What AOD-9604 Is
AOD-9604 is a synthetic peptide with the molecular formula C78H123N23O23S2 and a molecular weight of about 1815 g/mol (PubChem CID 71300630). Because no approved label exists, no confirmed mechanism of action or clinical use can be stated from available data.
Trial Footprint
Public trial registries reviewed show no currently registered clinical trials for AOD-9604. No trial phases, designs, or outcomes are available to summarize at this time.
FAQ
No. AOD-9604 has no FDA-approved label, no approved brand name, and no approved medical indication. It is classified as an unapproved research compound.
AOD-9604 is a synthetic peptide with a molecular formula of C78H123N23O23S2 and a molecular weight near 1815 g/mol. Beyond this chemical identity, no approved label information is available to describe its mechanism or use.
Public trial registries reviewed list no currently registered clinical trials for this compound. This means no trial phase, design, or outcome data is currently available to summarize.
No adverse event report data was available in the sources reviewed for this compound. This means no side effect pattern can currently be summarized.
There is no FDA-approved use for AOD-9604 and no clinical trial data reviewed here to support any specific health benefit. Its regulatory status remains unapproved and investigational only.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-08-03